1. - Clinica malattie apparato respiratorio

IL VOLTO DELLA BPCO CHE CAMBIA ● QUADERNO 6
36. Elliott MW, Confalonieri M, Nava S: Where to
perform noninvasive ventilation Eur Respir J 2002;
19(6):1159-1166.
37. Corrado A et al: Respiratory intermediate care
units: a European survey. Eur Respir J 2002;
20(5):1343-1350.
38. Confalonieri M et al: Respiratory intensive care
units in Italy: a national census and prospective
cohort study.Thorax 2001; 56(5):373-378.
39. Nava S, Confalonieri M, Rampulla C: Intermediate
respiratory intensive care units in Europe: a European
perspective.Thorax 1998; 53(9):798-802.
40. Corrado A e Confalonieri M: Respiratory high-dependency
care units in Italy. Monaldi Arch Chest
Dis 1999; 54(5):435-437.
41. Potena A et al: Le unità di terapia intensiva respiratoria
in italia: analisi dell’attività clinica e dei suoi
sistemi di codifica. Rass Pat App Resp 2002; 17:96-
105.
42. Ram FS, Lightowler JV, Wedzicha JA: Non-invasive
positive pressure ventilation for treatment of respiratory
failure due to exacerbations of chronic obstructive
pulmonary disease (Cochrane Review).
Cochrane Database Syst Rev 2003; 1:CD004104.
43. Lightowler JV et al: Non-invasive positive pressure
ventilation to treat respiratory failure resulting from
exacerbations of chronic obstructive pulmonary disease:
Cochrane systematic review and meta-analysis.
BMJ 2003; 326(7382):185.
44. Celli BR: Pulmonary rehabilitation in patients
with COPD. Am J Respir Crit Care Med 1995;
152(3): 861-864.
45. Lacasse Y et al: Pulmonary rehabilitation for chronic
obstructive pulmonary disease. Cochrane Database
Syst Rev 2002;3:CD003793.
46. Cambach W et al:The long-term effects of pulmonary
rehabilitation in patients with asthma and chronic
obstructive pulmonary disease: a research synthesis.
Arch Phys Med Rehabil 1999; 80(1):103-111.
47. Levin D et al: Effect of 15 hours per day oxygen
therapy on patients with chronic airways obstruction.
Chest 1980; 77(2 Suppl):307.
48. Flenley DC et al: Nocturnal hypoxemia and longterm
domiciliary oxygen therapy in “blue and bloated”bronchitics.Physiopathologic
correlations.Chest
1980; 77(2 Suppl):305-307.
49. Continuous or nocturnal oxygen therapy in hypoxemic
chronic obstructive lung disease: a clinical
trial. Nocturnal Oxygen Therapy Trial Group. Ann
Intern Med 1980; 93(3):391-398.
50. Long term domiciliary oxygen therapy in chronic
hypoxic cor pulmonale complicating chronic bronchitis
and emphysema. Report of the Medical Research
Council Working Party. Lancet 1981;
1(8222): 681-686.
51. Sergi M et al: Are COPD patients with nocturnal
REM sleep-related desaturations more prone to
developing chronic respiratory failure requiring
long-term oxygen therapy Respiration 2002,
69(2):117-122.
52. Crockett AJ et al: Domiciliary oxygen for chronic
obstructive pulmonary disease. Cochrane Database
Syst Rev 2000; 4:CD001744.
53. Wijkstra PJ et al: International approaches to the
prescription of long-term oxygen therapy. Eur Respir
J 2001; 18(6):909-913.
54. Ringbaek TJ, Lange P, Viskum K: Are patients on
long-term oxygen therapy followed up properly
Data from the Danish Oxygen Register. J Intern
Med 2001; 250(2):131-136.
55. Ram FS e Wedzicha JA:Ambulatory oxygen for chronic
obstructive pulmonary disease. Cochrane Database
Syst Rev 2002; 2:CD000238.
56. George CF e Bayliff CD: Management of insomnia
in patients with chronic obstructive pulmonary
disease. Drugs 2003; 63(4):379-387.
57. McNicholas WT: Impact of sleep in COPD. Chest
2000; 117(2 Suppl):48S-53S.
58. Dart RA et al:Treatment of systemic hypertension
in patients with pulmonary disease: COPD and
asthma. Chest 2003; 123(1):222-243.
59. Agusti AG et al: Systemic effects of chronic obstructive
pulmonary disease. Eur Respir J 2003;
21(2):347-360.
60. Rennard S et al: Impact of COPD in North America
and Europe in 2000: subjects’ perspective of
Confronting COPD International Survey. Eur Respir
J 2002; 20(4):799-805.
61. Rossi A e Confalonieri M: Burden of chronic obstructive
pulmonary disease. Lancet 2000; 356(Suppl):S56.
62. Rennard SI: Overview of causes of COPD. New
understanding of pathogenesis and mechanisms can
guide future therapy.Postgrad Med 2002;111(6):28-
30, 33-34, 37-38.
90